In NB tumors, we found that the expression of ALK-I19 significantly correlates with > 50% areas of undifferentiated histology, and a number of other known prognostic factors such as stage 4 disease, high-risk group and MYCN amplification. This evidence concerns the gene ALK and neuroblastoma.